TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
A

Agilent Technologies Inc

Healthcare · Diagnostics & Research

167.30$ +3.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement A
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
45.8% 45.2% 45.6% 45.8% 46.1% 46.5% 48.1% 47.4% 48.2% 47.4% 45.0% 44.5% 46.3%
54.2% 54.8% 54.4% 54.2% 53.9% 53.5% 51.9% 52.6% 51.8% 52.6% 55.0% 55.5% 53.7%
6.8% 7.7% 7.2% 8.0% 6.5% 6.7% 6.7% 6.4% 6.4% 6.5% 6.9% 6.5% 6.6%
35.1% 23.9% 24.2% 25.0% 21.2% 24.4% 27.2% 24.0% 23.0% 26.5% 25.3% 25.3% 25.0%
30.0% 31.6% 31.3% 33.1% 29.9% 31.1% 33.9% 31.9% 28.0% 33.0% 33.2% 31.8% 31.5%
24.2% 23.2% 23.1% 21.1% 24.0% 22.4% 18.0% 20.7% 23.8% 19.6% 21.7% 23.6% 22.2%
1.3% 1.3% 1.3% 1.4% 1.9% 1.7% 1.7% 1.6% 1.5% 1.4% 1.4% 1.5% 1.4%
24.9% 24.3% 23.8% 21.7% 23.6% 21.8% 15.6% 21.1% 23.8% 20.2% 22.2% 23.6% 22.5%
-3.3% 3.3% 4.2% 3.9% 2.9% 2.9% 2.7% 1.7% 0.4% 3.3% 3.8% 4.4% 3.0%
28.1% 21.0% 19.6% 17.9% 20.6% 18.9% 12.9% 19.3% 23.3% 17.0% 18.5% 19.3% 19.5%
29.9% 29.4% 27.7% 27.1% 29.5% 27.8% 21.7% 26.8% 29.0% 25.4% 27.2% 25.2% 26.7%

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?